MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202641082780 A) filed by Andtil Healthcare Private Limited on July 06, 2026, for Circadian-Optimized Synbiotic Psychobiotic Protein Formulation.
Inventors include Manjunath Patil; and Bonthala Satyaprakash Smitha.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: Circadian-optimized synbiotic psychobiotic protein formulation The present invention discloses a chronobiologically optimized synbiotic psychobiotic composition and method for managing metabolic syndrome and modulating the gut-brain axis. The formulation comprises at least one protein source, at least one prebiotic fiber matrix, a multi-enzyme blend, and at least one psychobiotic culture blend, configured to synergistically support sustained short-chain fatty acid (SCFA) production, particularly butyrate. By optimally aligning administration with peak circadian metabolic windows (for example, between 10:00 AM and 2:00 PM), the invention significantly enhances satiety, restores microbial balance, strengthens gut barrier integrity, and reduces systemic inflammation. The highly customizable, integrated formulation addresses the root causes of dysbiosis and insulin resistance, providing a holistic, non-pharmacological intervention that simultaneously improves neurocognitive health and overall metabolic efficiency.
Disclaimer: Curated by HT Syndication.
